Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2131 entries
Sorted by: Best Match Show Resources per page
Sexual dimorphism in the hypophysiotropic tyrosine hydroxylase-positive neurons in the preoptic area of the teleost, Clarias batrachus.

Biology of sex differences

Saha S, Patil S, Singh U, Singh O, Singru PS.
PMID: 26557978
Biol Sex Differ. 2015 Nov 09;6:23. doi: 10.1186/s13293-015-0042-x. eCollection 2015.

BACKGROUND: Dopamine (DA) neurons in the anteroventral periventricular nucleus (AVPV) in the preoptic area (POA) of mammals express estrogen receptors, regulate luteinizing hormone (LH) secretion, and show distinct sexual dimorphism. In teleosts, hypophysiotropic DA neurons of the nucleus preopticus...

Cite
Saha S, Patil S, Singh U, et al. Sexual dimorphism in the hypophysiotropic tyrosine hydroxylase-positive neurons in the preoptic area of the teleost, Clarias batrachus. Biol Sex Differ. 2015;6:23doi: 10.1186/s13293-015-0042-x.
Saha, S., Patil, S., Singh, U., Singh, O., & Singru, P. S. (2015). Sexual dimorphism in the hypophysiotropic tyrosine hydroxylase-positive neurons in the preoptic area of the teleost, Clarias batrachus. Biology of sex differences, 623. https://doi.org/10.1186/s13293-015-0042-x
Saha, Soham, et al. "Sexual dimorphism in the hypophysiotropic tyrosine hydroxylase-positive neurons in the preoptic area of the teleost, Clarias batrachus." Biology of sex differences vol. 6 (2015): 23. doi: https://doi.org/10.1186/s13293-015-0042-x
Saha S, Patil S, Singh U, Singh O, Singru PS. Sexual dimorphism in the hypophysiotropic tyrosine hydroxylase-positive neurons in the preoptic area of the teleost, Clarias batrachus. Biol Sex Differ. 2015 Nov 09;6:23. doi: 10.1186/s13293-015-0042-x. eCollection 2015. PMID: 26557978; PMCID: PMC4640419.
Copy Download .nbib Format: NLM
Post-Natal Dynamic Changes in Circulating Follicle-Stimulating Hormone, Luteinizing Hormone, Immunoreactive Inhibin, Progesterone, Testosterone and Estradiol-17β in Thoroughbred Colts until 6 Months of Age.

Journal of equine science

Dhakal P, Tsunoda N, Nakai R, Nagaoka K, Nambo Y, Sato F, Taniyama H, Taya K.
PMID: 24833982
J Equine Sci. 2011;22(1):9-15. doi: 10.1294/jes.22.9. Epub 2011 Apr 26.

The aim of present study was to clarify the post-natal profile of follicle-stimulating hormone (FSH), luteinizing hormone (LH), immunoreactive (ir)-inhibin, progesterone, testosterone, and estradiol-17β, and their relationships in Thoroughbred colts. Six hundred and thirty-six colts were used for the...

Cite
Dhakal P, Tsunoda N, Nakai R, et al. Post-Natal Dynamic Changes in Circulating Follicle-Stimulating Hormone, Luteinizing Hormone, Immunoreactive Inhibin, Progesterone, Testosterone and Estradiol-17β in Thoroughbred Colts until 6 Months of Age. J Equine Sci. 2011;22(1):9-15doi: 10.1294/jes.22.9.
Dhakal, P., Tsunoda, N., Nakai, R., Nagaoka, K., Nambo, Y., Sato, F., Taniyama, H., & Taya, K. (2011). Post-Natal Dynamic Changes in Circulating Follicle-Stimulating Hormone, Luteinizing Hormone, Immunoreactive Inhibin, Progesterone, Testosterone and Estradiol-17β in Thoroughbred Colts until 6 Months of Age. Journal of equine science, 22(1), 9-15. https://doi.org/10.1294/jes.22.9
Dhakal, Pramod, et al. "Post-Natal Dynamic Changes in Circulating Follicle-Stimulating Hormone, Luteinizing Hormone, Immunoreactive Inhibin, Progesterone, Testosterone and Estradiol-17β in Thoroughbred Colts until 6 Months of Age." Journal of equine science vol. 22,1 (2011): 9-15. doi: https://doi.org/10.1294/jes.22.9
Dhakal P, Tsunoda N, Nakai R, Nagaoka K, Nambo Y, Sato F, Taniyama H, Taya K. Post-Natal Dynamic Changes in Circulating Follicle-Stimulating Hormone, Luteinizing Hormone, Immunoreactive Inhibin, Progesterone, Testosterone and Estradiol-17β in Thoroughbred Colts until 6 Months of Age. J Equine Sci. 2011;22(1):9-15. doi: 10.1294/jes.22.9. Epub 2011 Apr 26. PMID: 24833982; PMCID: PMC4013995.
Copy Download .nbib Format: NLM
Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer.

Oncotarget

Wu J, Chen WK, Zhang W, Zhang JS, Liu JH, Jiang YM, Fang KW.
PMID: 28938674
Oncotarget. 2017 Aug 02;8(35):59709-59719. doi: 10.18632/oncotarget.19810. eCollection 2017 Aug 29.

This network meta-analysis was conducted to compare the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer (PC). The PubMed and Cochrane Library databases were searched for randomized controlled trials of treatments for advanced/metastatic PC. Eighteen studies...

Cite
Wu J, Chen WK, Zhang W, et al. Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer. Oncotarget. 2017;8(35):59709-59719doi: 10.18632/oncotarget.19810.
Wu, J., Chen, W. K., Zhang, W., Zhang, J. S., Liu, J. H., Jiang, Y. M., & Fang, K. W. (2017). Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer. Oncotarget, 8(35), 59709-59719. https://doi.org/10.18632/oncotarget.19810
Wu, Jing, et al. "Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer." Oncotarget vol. 8,35 (2017): 59709-59719. doi: https://doi.org/10.18632/oncotarget.19810
Wu J, Chen WK, Zhang W, Zhang JS, Liu JH, Jiang YM, Fang KW. Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer. Oncotarget. 2017 Aug 02;8(35):59709-59719. doi: 10.18632/oncotarget.19810. eCollection 2017 Aug 29. PMID: 28938674; PMCID: PMC5601770.
Copy Download .nbib Format: NLM
Cervical sympathectomy affects gonadotropin-releasing hormone, luteinizing hormone and testosterone in male rats.

Journal of anesthesia

Iwama H, Tase C, Tonosaki Y, Sugiura Y.
PMID: 28921287
J Anesth. 1995 Jun;9(2):166-169. doi: 10.1007/BF02479850.

To examine the effects of bilateral cervical sympathectomy on the secretion of gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH) and testosterone (TS), 24 male rats were divided into four groups: control (C), light (L), sympathectomy (S), and light-sympathectomy (LS) groups....

Cite
Iwama H, Tase C, Tonosaki Y, et al. Cervical sympathectomy affects gonadotropin-releasing hormone, luteinizing hormone and testosterone in male rats. J Anesth. 1995;9(2):166-169doi: 10.1007/BF02479850.
Iwama, H., Tase, C., Tonosaki, Y., & Sugiura, Y. (1995). Cervical sympathectomy affects gonadotropin-releasing hormone, luteinizing hormone and testosterone in male rats. Journal of anesthesia, 9(2), 166-169. https://doi.org/10.1007/BF02479850
Iwama, Hiroshi, et al. "Cervical sympathectomy affects gonadotropin-releasing hormone, luteinizing hormone and testosterone in male rats." Journal of anesthesia vol. 9,2 (1995): 166-169. doi: https://doi.org/10.1007/BF02479850
Iwama H, Tase C, Tonosaki Y, Sugiura Y. Cervical sympathectomy affects gonadotropin-releasing hormone, luteinizing hormone and testosterone in male rats. J Anesth. 1995 Jun;9(2):166-169. doi: 10.1007/BF02479850. PMID: 28921287.
Copy Download .nbib Format: NLM
Association between insulin resistance and estrogen in sexual precocity of obese children.

Experimental and therapeutic medicine

Lin S, Ji W.
PMID: 27703507
Exp Ther Med. 2016 Oct;12(4):2497-2500. doi: 10.3892/etm.2016.3663. Epub 2016 Sep 06.

The aim of the study was to examine the association between sexual precocity and high-molecular weight (HMW)-adiponectin and investigate the correlation of insulin resistance and estrogen levels in obese children. In total, 60 obese children (30 boys and 30...

Cite
Lin S, Ji W. Association between insulin resistance and estrogen in sexual precocity of obese children. Exp Ther Med. 2016;12(4):2497-2500doi: 10.3892/etm.2016.3663.
Lin, S., & Ji, W. (2016). Association between insulin resistance and estrogen in sexual precocity of obese children. Experimental and therapeutic medicine, 12(4), 2497-2500. https://doi.org/10.3892/etm.2016.3663
Lin, Shixia, and Ji, Wei. "Association between insulin resistance and estrogen in sexual precocity of obese children." Experimental and therapeutic medicine vol. 12,4 (2016): 2497-2500. doi: https://doi.org/10.3892/etm.2016.3663
Lin S, Ji W. Association between insulin resistance and estrogen in sexual precocity of obese children. Exp Ther Med. 2016 Oct;12(4):2497-2500. doi: 10.3892/etm.2016.3663. Epub 2016 Sep 06. PMID: 27703507; PMCID: PMC5038903.
Copy Download .nbib Format: NLM
CREB activity is required for luteinizing hormone-induced the expression of EGF-like factors.

Molecular reproduction and development

[No authors listed]
PMID: 28418630
Mol Reprod Dev. 2017 Apr;84(4):347. doi: 10.1002/mrd.22796. Epub 2017 Mar 29.

No abstract available.

Cite
CREB activity is required for luteinizing hormone-induced the expression of EGF-like factors. Mol Reprod Dev. 2017;84(4):347doi: 10.1002/mrd.22796.
(2017). CREB activity is required for luteinizing hormone-induced the expression of EGF-like factors. Molecular reproduction and development, 84(4), 347. https://doi.org/10.1002/mrd.22796
"CREB activity is required for luteinizing hormone-induced the expression of EGF-like factors." Molecular reproduction and development vol. 84,4 (2017): 347. doi: https://doi.org/10.1002/mrd.22796
CREB activity is required for luteinizing hormone-induced the expression of EGF-like factors. Mol Reprod Dev. 2017 Apr;84(4):347. doi: 10.1002/mrd.22796. Epub 2017 Mar 29. PMID: 28418630.
Copy Download .nbib Format: NLM
[Effectiveness and safety of degarelix in treating hormone-sensitive prostate cancer: review of the recent literature].

Urologiia (Moscow, Russia : 1999)

Govorov AV, Vasil'ev AO, Pushkar DY.
PMID: 28394542
Urologiia. 2016 Dec;6:110-114.

Since their first clinical use in 1990 and up to the present time, the luteinizing hormone-releasing hormone (LHRH) analogues have formed the mainstay of androgen deprivation therapy of patients with hormone-sensitive prostate cancer. The transient testosterone surge inherent in...

Cite
Govorov AV, Vasil'ev AO, Pushkar DY. [Effectiveness and safety of degarelix in treating hormone-sensitive prostate cancer: review of the recent literature]. Urologiia. 2016;6:110-114
Govorov, A. V., Vasil'ev, A. O., & Pushkar, D. Y. (2016). [Effectiveness and safety of degarelix in treating hormone-sensitive prostate cancer: review of the recent literature]. Urologiia (Moscow, Russia : 1999), 6110-114.
Govorov, A V, et al. "[Effectiveness and safety of degarelix in treating hormone-sensitive prostate cancer: review of the recent literature]." Urologiia (Moscow, Russia : 1999) vol. 6 (2016): 110-114.
Govorov AV, Vasil'ev AO, Pushkar DY. [Effectiveness and safety of degarelix in treating hormone-sensitive prostate cancer: review of the recent literature]. Urologiia. 2016 Dec;6:110-114. Russian. PMID: 28394542.
Copy Download .nbib Format: NLM
Analysis of the clinical and molecular characteristics of a child with achondroplasia: A case report.

Experimental and therapeutic medicine

Liu J, Tang X, Cheng J, Wang L, Yang X, Wang Y.
PMID: 26136890
Exp Ther Med. 2015 May;9(5):1763-1767. doi: 10.3892/etm.2015.2324. Epub 2015 Mar 02.

Achondroplasia (ACH) is a hereditary dwarfism caused by the disturbed proliferation and differentiation of growth plate chondrocytes, followed by impaired endochondral bone growth. ACH is caused by mutations in the gene encoding the transmembrane receptor, fibroblast growth factor receptor...

Cite
Liu J, Tang X, Cheng J, et al. Analysis of the clinical and molecular characteristics of a child with achondroplasia: A case report. Exp Ther Med. 2015;9(5):1763-1767doi: 10.3892/etm.2015.2324.
Liu, J., Tang, X., Cheng, J., Wang, L., Yang, X., & Wang, Y. (2015). Analysis of the clinical and molecular characteristics of a child with achondroplasia: A case report. Experimental and therapeutic medicine, 9(5), 1763-1767. https://doi.org/10.3892/etm.2015.2324
Liu, Jingfang, et al. "Analysis of the clinical and molecular characteristics of a child with achondroplasia: A case report." Experimental and therapeutic medicine vol. 9,5 (2015): 1763-1767. doi: https://doi.org/10.3892/etm.2015.2324
Liu J, Tang X, Cheng J, Wang L, Yang X, Wang Y. Analysis of the clinical and molecular characteristics of a child with achondroplasia: A case report. Exp Ther Med. 2015 May;9(5):1763-1767. doi: 10.3892/etm.2015.2324. Epub 2015 Mar 02. PMID: 26136890; PMCID: PMC4471706.
Copy Download .nbib Format: NLM
Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers.

Nanoscale research letters

Cao LB, Zeng S, Zhao W.
PMID: 27325521
Nanoscale Res Lett. 2016 Dec;11(1):305. doi: 10.1186/s11671-016-1509-3. Epub 2016 Jun 21.

In the present study, a highly stable luteinizing-hormone-releasing hormone (LHRH)-conjugated PEGylated poly(lactic-co-glycolic acid) (PLGA) nanoparticles were developed for the successful treatment of prostate cancers. We have demonstrated that a unique combination of targeted drug delivery and controlled drug release...

Cite
Cao LB, Zeng S, Zhao W. Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers. Nanoscale Res Lett. 2016;11(1):305doi: 10.1186/s11671-016-1509-3.
Cao, L. B., Zeng, S., & Zhao, W. (2016). Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers. Nanoscale research letters, 11(1), 305. https://doi.org/10.1186/s11671-016-1509-3
Cao, Long-Bin, et al. "Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers." Nanoscale research letters vol. 11,1 (2016): 305. doi: https://doi.org/10.1186/s11671-016-1509-3
Cao LB, Zeng S, Zhao W. Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers. Nanoscale Res Lett. 2016 Dec;11(1):305. doi: 10.1186/s11671-016-1509-3. Epub 2016 Jun 21. PMID: 27325521; PMCID: PMC4916070.
Copy Download .nbib Format: NLM
Adrenocortical zonation, renewal, and remodeling.

Frontiers in endocrinology

Pihlajoki M, Dörner J, Cochran RS, Heikinheimo M, Wilson DB.
PMID: 25798129
Front Endocrinol (Lausanne). 2015 Mar 05;6:27. doi: 10.3389/fendo.2015.00027. eCollection 2015.

The adrenal cortex is divided into concentric zones. In humans the major cortical zones are the zona glomerulosa, zona fasciculata, and zona reticularis. The adrenal cortex is a dynamic organ in which senescent cells are replaced by newly differentiated...

Cite
Pihlajoki M, Dörner J, Cochran RS, et al. Adrenocortical zonation, renewal, and remodeling. Front Endocrinol (Lausanne). 2015;6:27doi: 10.3389/fendo.2015.00027.
Pihlajoki, M., Dörner, J., Cochran, R. S., Heikinheimo, M., & Wilson, D. B. (2015). Adrenocortical zonation, renewal, and remodeling. Frontiers in endocrinology, 627. https://doi.org/10.3389/fendo.2015.00027
Pihlajoki, Marjut, et al. "Adrenocortical zonation, renewal, and remodeling." Frontiers in endocrinology vol. 6 (2015): 27. doi: https://doi.org/10.3389/fendo.2015.00027
Pihlajoki M, Dörner J, Cochran RS, Heikinheimo M, Wilson DB. Adrenocortical zonation, renewal, and remodeling. Front Endocrinol (Lausanne). 2015 Mar 05;6:27. doi: 10.3389/fendo.2015.00027. eCollection 2015. PMID: 25798129; PMCID: PMC4350438.
Copy Download .nbib Format: NLM
A conjugate of methotrexate and an analog of luteinizing hormone releasing hormone shows increased efficacy against prostate cancer.

Scientific reports

Zhu S, Wang Q, Jiang J, Luo Y, Sun Z.
PMID: 27654169
Sci Rep. 2016 Sep 22;6:33894. doi: 10.1038/srep33894.

LHRH receptor, is over-expressed in a variety of human tumors and, is a potential binding site for targeted metastatic prostate cancer therapy. The objectives of our study were to synthesize a bioconjugate of the LHRH analog [DLys

Cite
Zhu S, Wang Q, Jiang J, et al. A conjugate of methotrexate and an analog of luteinizing hormone releasing hormone shows increased efficacy against prostate cancer. Sci Rep. 2016;6:33894doi: 10.1038/srep33894.
Zhu, S., Wang, Q., Jiang, J., Luo, Y., & Sun, Z. (2016). A conjugate of methotrexate and an analog of luteinizing hormone releasing hormone shows increased efficacy against prostate cancer. Scientific reports, 633894. https://doi.org/10.1038/srep33894
Zhu, Shengsheng, et al. "A conjugate of methotrexate and an analog of luteinizing hormone releasing hormone shows increased efficacy against prostate cancer." Scientific reports vol. 6 (2016): 33894. doi: https://doi.org/10.1038/srep33894
Zhu S, Wang Q, Jiang J, Luo Y, Sun Z. A conjugate of methotrexate and an analog of luteinizing hormone releasing hormone shows increased efficacy against prostate cancer. Sci Rep. 2016 Sep 22;6:33894. doi: 10.1038/srep33894. PMID: 27654169; PMCID: PMC5032167.
Copy Download .nbib Format: NLM
Ascorbic acid treatment elevates follicle stimulating hormone and testosterone plasma levels and enhances sperm quality in albino Wistar rats.

Nigerian medical journal : journal of the Nigeria Medical Association

Okon UA, Utuk II.
PMID: 27185976
Niger Med J. 2016 Jan-Feb;57(1):31-6. doi: 10.4103/0300-1652.180570.

BACKGROUND: Infertility issues have been linked to the effect of oxidative reaction in the reproductive system. This study evaluated the effect of ascorbic acid, on fertility parameters of male albino Wistar rats was studied.MATERIALS AND METHODS: Eighteen albino Wistar...

Cite
Okon UA, Utuk II. Ascorbic acid treatment elevates follicle stimulating hormone and testosterone plasma levels and enhances sperm quality in albino Wistar rats. Niger Med J. 2016;57(1):31-6doi: 10.4103/0300-1652.180570.
Okon, U. A., & Utuk, I. I. (2016). Ascorbic acid treatment elevates follicle stimulating hormone and testosterone plasma levels and enhances sperm quality in albino Wistar rats. Nigerian medical journal : journal of the Nigeria Medical Association, 57(1), 31-6. https://doi.org/10.4103/0300-1652.180570
Okon, Uduak Akpan, and Utuk, Ikponoabasi Ibanga. "Ascorbic acid treatment elevates follicle stimulating hormone and testosterone plasma levels and enhances sperm quality in albino Wistar rats." Nigerian medical journal : journal of the Nigeria Medical Association vol. 57,1 (2016): 31-6. doi: https://doi.org/10.4103/0300-1652.180570
Okon UA, Utuk II. Ascorbic acid treatment elevates follicle stimulating hormone and testosterone plasma levels and enhances sperm quality in albino Wistar rats. Niger Med J. 2016 Jan-Feb;57(1):31-6. doi: 10.4103/0300-1652.180570. PMID: 27185976; PMCID: PMC4859110.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2131 entries